Logo image of PRZO

PARAZERO TECHNOLOGIES LTD (PRZO) Stock Fundamental Analysis

NASDAQ:PRZO - Nasdaq - IL0011857013 - Common Stock - Currency: USD

0.8868  -0.01 (-1.46%)

After market: 0.8843 0 (-0.28%)

Fundamental Rating

2

Taking everything into account, PRZO scores 2 out of 10 in our fundamental rating. PRZO was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. PRZO may be in some trouble as it scores bad on both profitability and health. PRZO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PRZO had negative earnings in the past year.
In the past year PRZO has reported a negative cash flow from operations.
PRZO had negative earnings in each of the past 5 years.
PRZO had a negative operating cash flow in each of the past 5 years.
PRZO Yearly Net Income VS EBIT VS OCF VS FCFPRZO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

PRZO has a worse Return On Assets (-227.98%) than 97.60% of its industry peers.
Industry RankSector Rank
ROA -227.98%
ROE N/A
ROIC N/A
ROA(3y)-126.97%
ROA(5y)-150.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRZO Yearly ROA, ROE, ROICPRZO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

PRZO has a Gross Margin of 10.82%. This is in the lower half of the industry: PRZO underperforms 75.20% of its industry peers.
PRZO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PRZO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.26%
GM growth 5YN/A
PRZO Yearly Profit, Operating, Gross MarginsPRZO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

3

2. Health

2.1 Basic Checks

PRZO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PRZO has been increased compared to 1 year ago.
PRZO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRZO Yearly Shares OutstandingPRZO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
PRZO Yearly Total Debt VS Total AssetsPRZO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

PRZO has an Altman-Z score of -9.18. This is a bad value and indicates that PRZO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.18, PRZO is doing worse than 92.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.18
ROIC/WACCN/A
WACC9.02%
PRZO Yearly LT Debt VS Equity VS FCFPRZO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

A Current Ratio of 3.87 indicates that PRZO has no problem at all paying its short term obligations.
The Current ratio of PRZO (3.87) is better than 76.00% of its industry peers.
A Quick Ratio of 3.57 indicates that PRZO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.57, PRZO belongs to the top of the industry, outperforming 82.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.57
PRZO Yearly Current Assets VS Current LiabilitesPRZO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for PRZO have decreased strongly by -28.80% in the last year.
The Revenue has grown by 50.23% in the past year. This is a very strong growth!
Measured over the past years, PRZO shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)-28.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)50.23%
Revenue growth 3Y8.99%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRZO Yearly Revenue VS EstimatesPRZO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PRZO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRZO Price Earnings VS Forward Price EarningsPRZO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRZO Per share dataPRZO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PRZO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARAZERO TECHNOLOGIES LTD

NASDAQ:PRZO (5/22/2025, 8:00:01 PM)

After market: 0.8843 0 (-0.28%)

0.8868

-0.01 (-1.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.61%
Inst Owner ChangeN/A
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap14.79M
AnalystsN/A
Price TargetN/A
Short Float %6.36%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.07
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -227.98%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.82%
FCFM N/A
ROA(3y)-126.97%
ROA(5y)-150.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-44.26%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 353.95%
Cap/Sales 6.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.87
Quick Ratio 3.57
Altman-Z -9.18
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)184.94%
Cap/Depr(5y)120.97%
Cap/Sales(3y)4.87%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)50.23%
Revenue growth 3Y8.99%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-126.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.4%
OCF growth 3YN/A
OCF growth 5YN/A